New Mexico company supports potency sufferers with access to workers’ compensation

Bennabis Health recently announced that its medicinal cannabis program is now available to patients residing in New Mexico. The Company has partnered with AltaVida Dispensary in Albuquerque to help medical cannabis patients, particularly those dealing with work-related injuries, where a patient wishes to use cannabis as a medicine for chronic pain.

“This is a tremendously exciting step in Bennabis Health’s growth as a visionary company that paves the way for those who can benefit most from medical cannabis where there is otherwise no coverage,” said Don Parisi, President of Bennabis Health. “Opening our network in New Mexico with AltaVida helps us move forward in our mission to deliver medicinal cannabis benefits across the country.”

The New Mexico Workers’ Compensation states that medicinal cannabis may be used by an injured worker “if deemed to provide ‘reasonable and necessary care’ under the Workers’ Compensation Act”. However, patients must pay out of pocket and will be reimbursed later.

“In certain states, such as New Mexico and New Jersey, worker compensation claims may require medical marijuana reimbursement from the airline if it provides appropriate and necessary treatment as a reasonable alternative to opioids,” the press release said from Bennabis Health. “In these cases, however, the aggrieved worker would have to pay a significant amount per month for their medical marijuana out of pocket and then seek reimbursement from their payer.”

Bennabis Health provides what is called a “layer of protection between the dispensary and the payer” through its membership program and a team of health insurance and cannabis industry professionals. One of the founders, Anne M. Davis, originally discovered cannabis to treat her multiple sclerosis, but her health insurance did not cover her switch to medical cannabis because it is a federally illegal substance and a Schedule I drug.

Earlier this March, the company partnered with a pharmacy in New Jersey to offer similar benefits ahead of its expansion into New Mexico.

Sales for adult use began in New Mexico on April 1, 2022, but the state has had its medicinal cannabis program in place since 2010 (technically, the earliest cannabis-related legislation was enacted in 2007, called the Lynn and Erin Compassionate Use Act). . Since then, state law has undergone some revisions, such as B. Remedying supply bottlenecks in 2018 by increasing the crop cultivation limit from 450 to 2,500. In 2019, the state expanded patient rights and also added new qualifying conditions for medical cannabis use.

Most recently, the New Mexico Cannabis Control Division reported sales for the month of November, showing a decline in medicinal cannabis sales and a steady increase in adult-use sales. Medicinal cannabis sales were recorded at $14 million, down $660,000 from October. Back in April 2022, when adult cannabis sales began, medicinal cannabis sales were $17 million.

As of December 5, the state also began issuing medical cannabis cards digitally.

On December 6th, the University of New Mexico (UNM) announced that one of its engineering professors, Nathan Jackson, is a principal investigator on a project aimed at finding a way to make cannabis-based vaping safer. “Any vapor device works by heating the liquid to more than 200 degrees Celsius, which creates toxic byproducts that then get into the aerosol droplets that are inhaled,” Jackson said. “Our technology uses a different mechanism to create the aerosol that doesn’t require heating, potentially eliminating the harmful by-products.” The project is called Droplet and Metal Particle Analysis of ENDS, and was co-sponsored by the UNM Comprehensive Cancer Center awarded a pilot prize.

“Our technology uses a silicon substrate that eliminates metal contact with the liquid and uses less heat, potentially allowing us to reduce the health risks associated with vaping,” Jackson explained. “Also, our technology can create micro-scale droplets instead of the nano-scale droplets found in current vaping devices, meaning droplets are less likely to enter the bloodstream and clump together, which could also result in safer aerosols.”

Post a comment:

Your email address will not be published. Required fields are marked *